Related Experiment Videos
[Systemic disease closely related to Cogan's syndrome (author's transl)]
Insights
Cogan's syndrome, a rare autoimmune disorder, can affect multiple organs. This case study highlights new pulmonary manifestations and successful treatment with corticosteroids and azathioprine, improving vascular and ocular symptoms.
Area of Science:
- Ophthalmology
- Rheumatology
- Internal Medicine
Background:
- Cogan's syndrome is a rare autoimmune disorder characterized by interstitial keratitis and sensorineural hearing loss.
- The syndrome is associated with systemic vascular inflammation, though specific manifestations can vary.
Observation:
- A 51-year-old patient with Cogan's syndrome was monitored for 8 years.
- The patient exhibited digital arterial occlusions and, uniquely, recurrent pulmonary infiltrations.
- Ocular and vascular symptoms were present, consistent with known Cogan's syndrome presentations.
Findings:
- This case describes previously unreported pulmonary involvement in Cogan's syndrome.
- Systemic corticosteroids and azathioprine effectively managed ocular and vascular symptoms.
- The patient achieved a three-year remission from recurrence, excluding inner ear hearing loss.
Implications:
- The findings expand the understanding of Cogan's syndrome's potential organ manifestations, particularly pulmonary involvement.
- Combined immunosuppressive therapy demonstrates efficacy in managing systemic inflammation and associated symptoms.
- Long-term monitoring and a multidisciplinary approach are crucial for managing this rare syndrome.
Abstract:
In a 51-year-old patient with non-syphilitic interstitial keratitis and disturbances of inner ear function (Cogan's syndrome) the course of the disease could be followed for 8 years. Organ manifestations which indicated generalised vascular disease were present in accordance with reports in the literature of this rare syndrome. In addition to multiple digital arterial occlusions, recurrent pulmonary infiltrations were observed which have not previously been described in connection with this syndrome. With the exception of the inner ear hearing loss the symptoms could be improved by systemic administration of corticosteroids and azathioprine. The patient remained free of recurrence for over three years.